Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder: Prevention in the Context of New Trauma

Overview

Journal R I Med J (2013)

Specialty General Medicine

Date 2023 Feb 27

PMID 36848535

Authors

McKenna C Brennan

Noah S Philip

Affiliations

Soon will be listed here.

Abstract

Posttraumatic stress disorder (PTSD) is a disabling psychiatric disorder that can result from experiencing a traumatic event. While a single index trauma can result in PTSD, patients often have additional traumatic events over the course of their lives. Despite this, little research to date has focused on prevention of PTSD recurrence following a novel traumatic experience. We present three cases of individuals with chronic PTSD who experienced an additional traumatic experience during treatment with transcranial magnetic stimulation (TMS) at VA Providence. Despite expectations to the contrary, TMS appeared to prevent a recurrence or worsening of their PTSD symptoms. We discuss possible neurobiological explanations for these outcomes and implications for possible use of TMS to prevent PTSD following trauma.

References

OReardon J, Solvason H, Janicak P, Sampson S, Isenberg K, Nahas Z . Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007; 62(11):1208-16. DOI: 10.1016/j.biopsych.2007.01.018. View

Dedert E, Green K, Calhoun P, Yoash-Gantz R, Taber K, Mumford M . Association of trauma exposure with psychiatric morbidity in military veterans who have served since September 11, 2001. J Psychiatr Res. 2009; 43(9):830-6. PMC: 2754834. DOI: 10.1016/j.jpsychires.2009.01.004. View

Clancy C, Graybeal A, Tompson W, Badgett K, Feldman M, Calhoun P . Lifetime trauma exposure in veterans with military-related posttraumatic stress disorder: association with current symptomatology. J Clin Psychiatry. 2006; 67(9):1346-53. DOI: 10.4088/jcp.v67n0904. View

Blevins C, Weathers F, Davis M, Witte T, Domino J . The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and Initial Psychometric Evaluation. J Trauma Stress. 2015; 28(6):489-98. DOI: 10.1002/jts.22059. View

Pitman R, Sanders K, Zusman R, Healy A, Cheema F, Lasko N . Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry. 2002; 51(2):189-92. DOI: 10.1016/s0006-3223(01)01279-3. View

Kessler R, Berglund P, Demler O, Jin R, Merikangas K, Walters E . Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62(6):593-602. DOI: 10.1001/archpsyc.62.6.593. View

Rachid F . Maintenance repetitive transcranial magnetic stimulation (rTMS) for relapse prevention in with depression: A review. Psychiatry Res. 2017; 262:363-372. DOI: 10.1016/j.psychres.2017.09.009. View

Kessler R . Posttraumatic stress disorder: the burden to the individual and to society. J Clin Psychiatry. 2000; 61 Suppl 5:4-12; discussion 13-4. View

Huang M, Yurgil K, Robb A, Angeles A, Diwakar M, Risbrough V . Voxel-wise resting-state MEG source magnitude imaging study reveals neurocircuitry abnormality in active-duty service members and veterans with PTSD. Neuroimage Clin. 2014; 5:408-19. PMC: 4145534. DOI: 10.1016/j.nicl.2014.08.004. View

10.

Bertolini F, Robertson L, Bisson J, Meader N, Churchill R, Ostuzzi G . Early pharmacological interventions for universal prevention of post-traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2022; 2:CD013443. PMC: 8829470. DOI: 10.1002/14651858.CD013443.pub2. View

11.

Petrosino N, Cosmo C, Berlow Y, Zandvakili A, van t Wout-Frank M, Philip N . Transcranial magnetic stimulation for post-traumatic stress disorder. Ther Adv Psychopharmacol. 2021; 11:20451253211049921. PMC: 8558793. DOI: 10.1177/20451253211049921. View

12.

Philip N, Barredo J, Aiken E, Carpenter L . Neuroimaging Mechanisms of Therapeutic Transcranial Magnetic Stimulation for Major Depressive Disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018; 3(3):211-222. PMC: 5856477. DOI: 10.1016/j.bpsc.2017.10.007. View

13.

Kroenke K, Spitzer R, Williams J . The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16(9):606-13. PMC: 1495268. DOI: 10.1046/j.1525-1497.2001.016009606.x. View

14.

Madore M, Kozel F, Williams L, Green L, George M, Holtzheimer P . Prefrontal transcranial magnetic stimulation for depression in US military veterans - A naturalistic cohort study in the veterans health administration. J Affect Disord. 2021; 297:671-678. PMC: 8667345. DOI: 10.1016/j.jad.2021.10.025. View

15.

Fulton J, Calhoun P, Wagner H, Schry A, Hair L, Feeling N . The prevalence of posttraumatic stress disorder in Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans: a meta-analysis. J Anxiety Disord. 2015; 31:98-107. DOI: 10.1016/j.janxdis.2015.02.003. View

16.

Schnurr P, Lunney C, Sengupta A, Waelde L . A descriptive analysis of PTSD chronicity in Vietnam veterans. J Trauma Stress. 2003; 16(6):545-53. DOI: 10.1023/B:JOTS.0000004077.22408.cf. View